Brief: Xbrane Biopharma Q4 EBITDA SEK -69.2 Million

Xbrane Biopharma AB

26/02/2024 07:00

Feb 26 (Reuters) - Xbrane Biopharma Q4 EPS SEK -5.28.
* Q4 net income SEK -157.5 million
* Q4 revenue SEK 66.9 million